Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients.

Mustacchi, G

Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients. [electronic resource] - Future oncology (London, England) 2015 - 1493-500 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1744-8301

10.2217/fon.15.34 doi


Aged
Aged, 80 and over
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Follow-Up Studies
Humans
Italy
Middle Aged
Neoplasm Staging
Receptor, ErbB-2--antagonists & inhibitors
Survival Analysis
Trastuzumab--pharmacology
Treatment Outcome